US approved the Pfizer COVID booster for the elderly and high-risk
Written by DZAT on September 25, 2021
The United States has authorized the use of Pfizer COVID-19 booster shots in individuals age 65-and-older as well as in others considered high risk because of their inherent disease and high-exposure jobs.
It is estimated that up to millions of Americans will be eligible for the third shot, six months after they receive their second dose.
The said decision is also expected following the convening of the regulatory body in the independent expert panel where they voted in favor of booster shots.
However, the panel rejected the White House’s initial plan to give full approval to Pfizer boosters to all ages 16-and-up.
The group of experts pointed out that the benefit-risk balance is different in younger populations, especially in younger men who have a greater chance of developing myocarditis.